Emergency Resuscitative Endovascular Balloon Occlusion of the Aorta in Out of Hospital Cardiac Arrest

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study will assess the feasibility of performing pre-hospital resuscitative endovascular balloon occlusion of the aorta (REBOA) as an adjunct to conventional Advanced Life Support (ALS) in patients suffering from non-traumatic out of hospital cardiac arrest (OHCA). As well as providing valuable insights into the technical feasibility of performing this procedure as part of a resuscitation attempt, the study will also document the beneficial physiological effects of REBOA in this group of patients.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• Non-Traumatic OHCA in patients within the East of England area AND with a East Anglian Air Ambulance (EAAA) REBOA team in attendance

• Patients below or equal to 80yrs of age and above or equal to 18yrs of age, according to available information/estimate at scene

• No flow \<10 mins from data available (i.e. total period in OHCA with no CPR)

• In cardiac arrest (with no sustained ROSC) on arrival of the EAAA REBOA team

Locations
Other Locations
United Kingdom
East Anglian Air Ambulance
RECRUITING
Norwich
Contact Information
Primary
Paul Rees, MD(Res)
paul.rees@eaaa.org.uk
07976 406496
Backup
Kate Lachowycz, PhD
kate.lachowycz@eaaa.org.uk
07984 074 523
Time Frame
Start Date: 2024-06-04
Estimated Completion Date: 2026-04-01
Participants
Target number of participants: 20
Treatments
Other: Aortic balloon occulsion
Delivery of ER-REBOA catheter to achieve aortic occlusion during resuscitation for out of hospital cardiac arrest, refractory to conventional advanced life support
Sponsors
Collaborators: East Anglian Air Ambulance, The Drummond Foundation, The Dowager Countess Eleanor Peel Trust, Rosetrees Trust
Leads: Queen Mary University of London

This content was sourced from clinicaltrials.gov